Image (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 01)
Anagrelide Capsule
Product Images NDC 13668-462
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Anagrelide (NDC 13668-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 02)
The text presents the mean platelet count of patients with thrombocytosis secondary to myeloproliferative disorder during anagrelide therapy. The mean platelet count is measured in x10^L and ranged from 1200g to 207 during the 208 weeks of treatment. The number of subjects for each time point is also shown.*
Image (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 03)
05 Labels (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 04)
Anagrelide Capsules, USP, are a medication used as a platelet-reducing agent. Each capsule contains 0.5 mg of anagrelide base (as anagrelide hydrochloride, USP), and the recommended starting dosage is 0.5 mg 4 times a day or 1 mg twice a day, which can be adjusted if needed. The total daily dose should not exceed 10 mg. It is essential to keep the drug out of reach of children and store it at 20° to 25°C (68° to 77°F) in a light-resistant container with a child-resistant closure. The medication is manufactured by Torrent Pharmaceuticals Ltd., India, and is available in a pack of 30 capsules. The full details can be found in the package insert.*
1 mg Lab (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 05)
Biac capsules are a platelet-reducing agent manufactured by Torrent Pharmaceuticals. The capsules contain 1 mg of Anagrelide base and the recommended starting dosage should be maintained for at least one week, but dosage may require adjustment. The drug should be kept out of the reach of children and stored in a cool and dry place. Biac capsules should be dispensed in a light-resistant container with a child-resistant closure. Complete information on the dosage and administration of the drug can be found in a separate insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
